메뉴 건너뛰기
Journal of Infectious Diseases
Volumn 205, Issue 11, 2012, Pages 1765-1766
Dried blood spot analysis combined with limited sampling models can advance therapeutic drug monitoring of tuberculosis drugs
Author keywords

[No Author keywords available]
Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;
EID: 84861043474     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis270     Document Type: Letter
Times cited : (13)
References (6)
  • 1
    • 81055143909 scopus 로고    scopus 로고
    • Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability
    • Shrivastava S, Pasipanodya JG, Meek C, et al. Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability. J Infect Dis 2011; 204:1951-9.
    • (2011) J Infect Dis , vol.204 , pp. 1951-1959
    • Shrivastava, S.1    Pasipanodya, J.G.2    Meek, C.3
  • 2
    • 81055147075 scopus 로고    scopus 로고
    • Drug forgiveness and interpatient pharmacokinetic variability in tuberculosis
    • Dartois V. Drug forgiveness and interpatient pharmacokinetic variability in tuberculosis. J Infect Dis 2011; 204:1827-9.
    • (2011) J Infect Dis , vol.204 , pp. 1827-1829
    • Dartois, V.1
  • 3
    • 0036033914 scopus 로고    scopus 로고
    • Therapeutic drug monitoring in the treatment of tuberculosis
    • Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs 2002; 62:2169-83. (Pubitemid 35252827)
    • (2002) Drugs , vol.62 , Issue.15 , pp. 2169-2183
    • Peloquin, C.A.1
  • 4
    • 80053473777 scopus 로고    scopus 로고
    • Dried blood spots: A new tool for tuberculosis treatment optimization
    • Vu DH, Alffenaar JW, Edelbroek PM, et al. Dried blood spots: a new tool for tuberculosis treatment optimization. Curr Pharm Des 2011; 17:1-9.
    • (2011) Curr Pharm des , vol.17 , pp. 1-9
    • Vu, D.H.1    Alffenaar, J.W.2    Edelbroek, P.M.3
  • 5
    • 80051783211 scopus 로고    scopus 로고
    • Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis
    • Pranger AD, Kosterink JG, van Altena R, et al. Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis. Ther Drug Monit 2011; 33:350-4.
    • (2011) Ther Drug Monit , vol.33 , pp. 350-354
    • Pranger, A.D.1    Kosterink, J.G.2    Van Altena, R.3
  • 6
    • 75649136552 scopus 로고    scopus 로고
    • Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis
    • Alffenaar JW, Kosterink JG, van Altena R, et al. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Ther Drug Monit 2010; 32:97-101.
    • (2010) Ther Drug Monit , vol.32 , pp. 97-101
    • Alffenaar, J.W.1    Kosterink, J.G.2    Van Altena, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.